PE ratio relative to earnings growth — is the valuation justified?
| Symbol | Company | PEG | P/E | Growth | vs BMRN |
|---|---|---|---|---|---|
| INCY | Incyte Corporation | 0.25 | 15.7 | 62.7% | -96% |
| UTHR | United Therapeutics Corporation | 0.87 | 18.2 | 20.9% | -85% |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.50 | 19.9 | 5.7% | -38% |
| VRTX | Vertex Pharmaceuticals Incorporated | 3.67 | 30.0 | 8.2% | -35% |